European Asthma Research and Innovation Partnership (EARIP)
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2013
- Initiating Organization: European Commission Seventh Framework Programme (FP7)
- Initiator Type: Government
- Disease focus:
Asthma
Abstract
The European Asthma Research and Innovation Partnership (EARIP) is a consortium that aims to identify key gaps in the foundational knowledge of asthma and to develop research and development (R&D) plans throughout Europe to address the gaps. The project activities range from basic cell science research, to assessing and improving European healthcare systems.
Mission
Supported by the European Commission, EARIP is a three-year consortium that aims to convene asthma experts from across Europe to define research gaps to reduce the impact of asthma. The consortium’s activities include workshops, prioritization exercises, consensus strategies, and development and publication of a set of recommendations for asthma research. The eventual goal is to have a comprehensive R&D roadmap for asthma.
EARIP will target a number of asthma research areas to ensure that a comprehensive overview of all current research strategies from across Europe is included in the project road map. These include the following:
Consortium History
The accomplishments of EARIP are listed at http://earip.eu/deliverables-and-publications/
Financing
The total cost of this consortium is €781,000, with the European Commission contributing €500,000 through its Seventh Framework Programme.
Patient Engagement
Several European patient organizations are involved in EARIP.
Impact/Accomplishment
The accomplishments of EARIP are listed at http://earip.eu/deliverables-and-publications/
Links/Social Media Feed
Homepage |
|
Other website |
http://ec.europa.eu/research/health/medical-research/severe-chronic-diseases/projects/earip_en.html |
Points of Contact
EARIP Project Officer
Jessica Edwards (Asthma UK)
email: jedwards@asthma.org.uk
Address
18 Mansell Street
London
E1 8AA
UK
Sponsors & Partners
Asthma UK |
European Federation of Allergy & Airways Diseases Patients Associations |
European Lung Foundation |
GlaxoSmithKline |
Imperial College London |
Karolinska Institutet |
National and Kapodistrian University of Athens |
Novartis International AG |
Swiss Institute of Allergy and Asthma Research |
University of Lodz |
University of Southampton |